Blood pressure variability, dementia, and role of antihypertensive medications in older adults

Author:

Mahinrad Simin1,Bennett David A.2,Sorond Farzaneh A.1,Gorelick Philip B.1

Affiliation:

1. Department of Neurology Feinberg School of Medicine Northwestern University Chicago Illinois USA

2. Department of Neurological Sciences and Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois USA

Abstract

AbstractIntroductionWe assessed the association between visit‐to‐visit blood pressure variability (BPV) up to 12 years and subsequent dementia risk, and tested the modifying effect of antihypertensive medications.MethodsWe studied 2234 participants from two community‐based cohorts of older adults with normal cognition or mild cognitive impairment. Participants were followed through annual assessments for up to 27 years. Visit‐to‐visit BPV was quantified over 3, 6, 9, and 12 years, respectively.ResultsHigher systolic BPV (SBPV) during 3, 6, 9, and 12 years was associated with a subsequent increased risk of dementia, with hazard ratios ranging from 1.02 (95% confidence interval [CI]: 1.01–1.04) to 1.10 (95% CI: 1.05–1.16). The association between SBPV and dementia risk was stronger among participants not taking calcium channel blockers (p‐for interaction < 0.05).DiscussionAmong older adults, long‐term exposure to higher visit‐to‐visit SBPV is associated with an increased risk of dementia later in life, and calcium channel blockers may modify this association.Highlights Among adults aged >65, higher systolic blood pressure variability spanning 3–12 years is associated with an increased risk of dementia later in life. Single blood pressure measurement or mean blood pressure levels does not seem to associate with dementia risk among older adults. The association between systolic blood pressure variability and dementia risk is stronger among those not taking calcium channel blocker medications.

Funder

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3